Research Grants show all

NIH3

Patents show all

69Issued51Applications

SEC Filings show all

D5

SEC Form D Funding Events

DateOfferedSoldType
2015-01-12$12,545,173$12,030,171Equity, Other
2013-12-10$24,000,000$23,550,000Equity, Other
2012-03-12$12,430,800$11,990,135Equity, Other
2008-12-22UnknownUnknownOther (Paper Filing)

Key Executives

  • Daphne Preuss
    Executive Officer, Director
  • Henry Hirvela
    Executive Officer
  • George Arida
    Director
  • John Greaves
    Director
  • Sanford Grossman
    Director
  • John Hamer
    Director
  • Armand Lavoie
    Director
  • N/a Meghan Sharp
    Director
  • N/a Quant Investment Holdings I, LLC
    Promoter
  • N/a Venture Investors Early Stage Fund III Limited Partnership
    Promoter
  • N/a Unilever Swiss Holdings AG
    Promoter
  • N/a Foragen Technologies Limited Partnership
    Promoter
  • David Jessen
    Executive Officer
  • Kenneth Davenport
    Executive Officer
  • Jeff Widder
    Executive Officer
  • Steven E. Ducommun
    Executive Officer
  • Meghan Sharp
    Director
  • David Zimmerman
    Director
  • Robert Shapiro
    Director
  • Robert Saul
    Director
  • Ducommun Steven
    Executive Officer
  • David Woodburn
    Executive Officer
  • Cathryn Taylor
    Executive Officer
  • (USA) Inc. Macquarie Capital
    Promoter
  • Steven Ducommun
    Executive Officer
  • Troy Randolph
    Executive Officer
  • Jeffrey Widder
    Executive Officer